Clinical Trial: A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07760831) titled 'A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis' on July 31.

Brief Summary: The study is being conducted to evaluate the safety, tolerability and pharmakokinetics of HRS-7085 in adults.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Ulcerative Colitis

Intervention: DRUG: HRS-7085 tablets

HRS-7085 tablets

DRUG: Placebo

HRS-7085 tablet blank preparation

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....